Table 1. Baseline clinical characteristics of the patients.
| Ischemic stroke (n = 22) | No ischemic stroke (n = 151) | P-value | |
|---|---|---|---|
| Age, years | 71±8 | 69±11 | 0.35 |
| Female, n (%) | 7 (32) | 43 (28) | 0.26 |
| Underlying disease, n (%) | |||
| Congestive heart failure | 9 (41) | 56 (37) | 0.72 |
| Hypertension | 15(68) | 88 (58) | 0.38 |
| Diabetes | 1(5) | 14 (9) | 0.46 |
| Stroke or TIA | 9 (41) | 40 (26) | 0.16 |
| Vascular disease | 2 (9) | 15 (10) | 0.90 |
| CHA2DS2-VASc score | 3.3±1.6 | 3.2±1.5 | 0.38 |
| Echocardiographic findings | |||
| Left atrial dimension, mm | 45±9 | 46±11 | 0.81 |
| Ejection fraction, % | 56±9 | 54±10 | 0.61 |
| Medications, n (%) | |||
| Beta-blocker | 4 (18) | 24 (16) | 0.79 |
| Digitalis | 8 (36) | 65 (43) | 0.55 |
| Ca-channel blocker | 7 (32) | 35 (23) | 0.38 |
| ACE inhibitor | 7 (32) | 37 (25) | 0.47 |
| Diuretics | 9 (41) | 56 (37) | 0.75 |
| Antiplatelet | 5 (23) | 41 (27) | 0.66 |
| Warfarin | 10 (45) | 83 (55) | 0.40 |
Ischemic stroke: patients who developed a stroke during the follow-up, No ischemic stroke: patients who remained ischemic stroke free during the follow-up. CHA2DS2-VASc score (acronym of Chronic heart failure, Hypertension, Age≥75 years, Diabetes, transient ischemic attack or Stroke, Vascular disease, Age≥65 years, and female sex). TIA: transient ischemic attack, ACE: angiotensin II converting enzyme. Data represent the mean±SD or frequency.